标题
Molecular mechanisms of drug resistance in ovarian cancer
作者
关键词
-
出版物
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 233, Issue 6, Pages 4546-4562
出版商
Wiley
发表日期
2017-11-20
DOI
10.1002/jcp.26289
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Epigenetic Pathways Offer Targets for Ovarian Cancer Treatment
- (2018) Melina-Theoni Gyparaki et al. Clinical Breast Cancer
- Updates of the role of oxidative stress in the pathogenesis of ovarian cancer
- (2017) Ghassan M. Saed et al. GYNECOLOGIC ONCOLOGY
- Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria
- (2017) Allimuthu T. Dharmaraja JOURNAL OF MEDICINAL CHEMISTRY
- Nitroxide radical-containing nanoparticles as potential candidates for overcoming drug resistance in epidermoid cancers
- (2017) Babita Shashni et al. POLYMER
- ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells
- (2016) Aparajitha Vaidyanathan et al. BRITISH JOURNAL OF CANCER
- Long Noncoding RNAs in Cancer Pathways
- (2016) Adam M. Schmitt et al. CANCER CELL
- Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in Glioblastoma
- (2016) Wei Wei et al. CANCER CELL
- Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism
- (2016) Zhihong Ai et al. CANCER LETTERS
- Genetic polymorphisms of human UDP-glucuronosyltransferase (UGT) genes and cancer risk
- (2016) Dong Gui Hu et al. DRUG METABOLISM REVIEWS
- Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters
- (2016) Xupeng Bai et al. DRUG METABOLISM REVIEWS
- Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions
- (2016) Nicolette G. Alkema et al. DRUG RESISTANCE UPDATES
- A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis
- (2016) Mckenna Longacre et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SiRNA and epigenetic aberrations in ovarian cancer
- (2016) HamidReza Mirzaei et al. Journal of Cancer Research and Therapeutics
- Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy
- (2016) Huimin Bai et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
- (2016) Bowen Du et al. MOLECULES
- NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer
- (2016) A R Özeş et al. ONCOGENE
- Redox Control of Multidrug Resistance and Its Possible Modulation by Antioxidants
- (2016) Aysegul Cort et al. Oxidative Medicine and Cellular Longevity
- Understanding the Genetic Mechanisms of Cancer Drug Resistance Using Genomic Approaches
- (2016) Xueda Hu et al. TRENDS IN GENETICS
- Role of long non-coding RNA in tumor drug resistance
- (2016) Heng Deng et al. TUMOR BIOLOGY
- Molecular mechanisms of peritoneal dissemination in gastric cancer
- (2016) Mitsuro Kanda et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
- (2016) Chi Lam Au Yeung et al. Nature Communications
- Altered glutamine metabolism in platinum resistant ovarian cancer
- (2016) Chantelle D. Hudson et al. Oncotarget
- Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer
- (2015) Jane Borley et al. ANNALS OF MEDICINE
- miRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT activation
- (2015) Delinaer Wuerkenbieke et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma
- (2015) Xiao Li et al. BMC CANCER
- Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer
- (2015) K-F Hsu et al. BRITISH JOURNAL OF CANCER
- The role of ABC transporters in ovarian cancer progression and chemoresistance
- (2015) M.P. Ween et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Metabolic and mind shifts
- (2015) Cyril Corbet et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells
- (2015) Ryan Charles Pink et al. GYNECOLOGIC ONCOLOGY
- Diverse Roles of SIRT1 in Cancer Biology and Lipid Metabolism
- (2015) Glenn Simmons et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC)
- (2015) Ting Shuang et al. MEDICAL ONCOLOGY
- miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway
- (2015) Marijn T. M. van Jaarsveld et al. Molecular Cancer
- NRP1 is targeted by miR-130a and miR-130b, and is associated with multidrug resistance in epithelial ovarian cancer based on integrated gene network analysis
- (2015) CHANGXIAN CHEN et al. Molecular Medicine Reports
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin
- (2015) X Zhu et al. ONCOGENE
- Molecular determinants of chemotherapy resistance in ovarian cancer
- (2015) Megan Cooley et al. PHARMACOGENOMICS
- Dysregulated metabolism contributes to oncogenesis
- (2015) Matthew D. Hirschey et al. SEMINARS IN CANCER BIOLOGY
- Uridine Diphosphate-Glucuronosyltransferase (UGT) Xenobiotic Metabolizing Activity and Genetic Evolution in Pinniped Species
- (2015) Mayu Kakehi et al. TOXICOLOGICAL SCIENCES
- DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma
- (2015) Noriko Yamaguchi et al. TUMOR BIOLOGY
- MicroRNA-9 promotes tumorigenesis and mediates sensitivity to cisplatin in primary epithelial ovarian cancer cells
- (2015) Hong-Min Zhao et al. TUMOR BIOLOGY
- MiR-197 induces Taxol resistance in human ovarian cancer cells by regulating NLK
- (2015) Dongling Zou et al. TUMOR BIOLOGY
- Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer
- (2015) Jing Li et al. TUMOR BIOLOGY
- MiRNA-149 modulates chemosensitivity of ovarian cancer A2780 cells to paclitaxel by targeting MyD88
- (2015) Yueping Zhan et al. Journal of Ovarian Research
- MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1
- (2015) Kai-Xuan Sun et al. Journal of Ovarian Research
- The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer
- (2015) Yingying Zhou et al. Journal of Ovarian Research
- Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death
- (2015) Daniela Catanzaro et al. Oncotarget
- The role of interleukin-8 (IL-8) and IL-8 receptors in platinum response in high grade serous ovarian carcinoma
- (2015) Euan A. Stronach et al. Oncotarget
- Inhibitory effects of metformin at low concentration on epithelial–mesenchymal transition of CD44+CD117+ ovarian cancer stem cells
- (2015) Rongrong Zhang et al. Stem Cell Research & Therapy
- Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
- (2015) Nirmala Chandralega Kampan et al. Biomed Research International
- Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells
- (2015) Karolina Weiner-Gorzel et al. Cancer Medicine
- Immunotherapeutic approaches to ovarian cancer treatment
- (2015) Cariad Chester et al. Journal for ImmunoTherapy of Cancer
- Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer
- (2015) Dimitra T. Stefanou et al. PLoS One
- MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells
- (2015) Ningwei Li et al. PLoS One
- SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α
- (2015) Qilin Ao et al. Scientific Reports
- Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines
- (2014) L Sawers et al. BRITISH JOURNAL OF CANCER
- miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6
- (2014) Xiaolan Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells
- (2014) Juan Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oncogenes associated with drug resistance in ovarian cancer
- (2014) Xia Liu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin
- (2014) Carlos P. Huang et al. Metallomics
- Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer
- (2014) HENAN ZHAO et al. ONCOLOGY REPORTS
- Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
- (2014) Corine M. Beaufort et al. PLoS One
- microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition
- (2014) Aditya Parikh et al. Nature Communications
- A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancer
- (2014) Da Li et al. Scientific Reports
- A Paradoxical Chemoresistance and Tumor Suppressive Role of Antioxidant in Solid Cancer Cells: A Strange Case of Dr. Jekyll and Mr. Hyde
- (2014) Jolie Kiemlian Kwee Biomed Research International
- Apoptosis and Molecular Targeting Therapy in Cancer
- (2014) Mohamed Hassan et al. Biomed Research International
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Histones and Their Modifications in Ovarian Cancer – Drivers of Disease and Therapeutic Targets
- (2014) Deborah J. Marsh et al. Frontiers in Oncology
- Targeted therapies and clinical trials in ovarian cancer
- (2013) J. Dancey ANNALS OF ONCOLOGY
- Role of Nrf2 in Oxidative Stress and Toxicity
- (2013) Qiang Ma Annual Review of Pharmacology and Toxicology
- Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
- (2013) J H Huh et al. BRITISH JOURNAL OF CANCER
- Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development
- (2013) F. Baenke et al. Disease Models & Mechanisms
- Function of oncogenes in cancer development: a changing paradigm
- (2013) Carolina Vicente-Dueñas et al. EMBO JOURNAL
- Downregulation ofmiR-29contributes to cisplatin resistance of ovarian cancer cells
- (2013) Pei-Ning Yu et al. INTERNATIONAL JOURNAL OF CANCER
- Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer
- (2013) Carmen Pyragius et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas
- (2013) Yu-Quan Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Polymorphisms in the UGT1A1 gene predict adverse effects of irinotecan in the treatment of gynecologic cancer in Japanese patients
- (2013) Akira Hirasawa et al. JOURNAL OF HUMAN GENETICS
- Modulation of OATP1B-Type Transporter Function Alters Cellular Uptake and Disposition of Platinum Chemotherapeutics
- (2013) C. S. Lancaster et al. MOLECULAR CANCER THERAPEUTICS
- Antitumor Effect of SIRT1 Inhibition in Human HCC Tumor Models In Vitro and In Vivo
- (2013) S. Portmann et al. MOLECULAR CANCER THERAPEUTICS
- Latest research and treatment of advanced-stage epithelial ovarian cancer
- (2013) Robert L. Coleman et al. Nature Reviews Clinical Oncology
- MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine
- (2013) Y Xiang et al. ONCOGENE
- Upregulation of NEK2 is associated with drug resistance in ovarian cancer
- (2013) XIA LIU et al. ONCOLOGY REPORTS
- Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
- (2013) Ulrich M. Zanger et al. PHARMACOLOGY & THERAPEUTICS
- Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-κB and HSP27/p38/AKT Pathways and by Inhibiting ABCB1
- (2013) Jonathan T. Sims et al. PLoS One
- Transcriptional Suppression, DNA Methylation, and Histone Deacetylation of the Regulator of G-Protein Signaling 10 (RGS10) Gene in Ovarian Cancer Cells
- (2013) Mourad W. Ali et al. PLoS One
- SNAI1-Mediated Epithelial-Mesenchymal Transition Confers Chemoresistance and Cellular Plasticity by Regulating Genes Involved in Cell Death and Stem Cell Maintenance
- (2013) Soyoung Lim et al. PLoS One
- The Long Noncoding RNA HOTAIR Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma Cells via downregualtion of p21WAF1/CIP1 Expression
- (2013) Zhili Liu et al. PLoS One
- The Role of Oxidative Stress in the Development of Cisplatin Resistance in Epithelial Ovarian Cancer
- (2013) Jimmy Belotte et al. Reproductive Sciences
- Nucleotide Excision Repair in Eukaryotes
- (2013) O. D. Scharer Cold Spring Harbor Perspectives in Biology
- Targeting cellular metabolism to improve cancer therapeutics
- (2013) Y Zhao et al. Cell Death & Disease
- miR-21 modulates paclitaxel sensitivity and hypoxia-inducible factor-1α expression in human ovarian cancer cells
- (2013) ZHONGBIN XIE et al. Oncology Letters
- Mechanisms and insights into drug resistance in cancer
- (2013) Hiba Zahreddine et al. Frontiers in Pharmacology
- Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET
- (2013) T Mitamura et al. Oncogenesis
- Metabolic changes in cancer: beyond the Warburg effect
- (2012) W. Wu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum
- (2012) Ahmed Y. Ali et al. Annals of the New York Academy of Sciences
- EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
- (2012) Alexandria M Haslehurst et al. BMC CANCER
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
- (2012) Paul D. Ray et al. CELLULAR SIGNALLING
- Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
- (2012) Roel H. Wilting et al. DRUG RESISTANCE UPDATES
- BRCA1epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer
- (2012) Olafur A. Stefansson et al. Epigenetics
- MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells
- (2012) Weiwei Cheng et al. FEBS Journal
- Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
- (2012) Xin Fu et al. FEBS LETTERS
- SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
- (2012) Chu-Xia Deng International Journal of Biological Sciences
- Deficient DNA Damage Signaling Leads to Chemoresistance to Cisplatin in Oral Cancer
- (2012) L. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Genetic Variation That Predicts Platinum Sensitivity Reveals the Role of miR-193b* in Chemotherapeutic Susceptibility
- (2012) D. Ziliak et al. MOLECULAR CANCER THERAPEUTICS
- Classification Models for Predicting Cytochrome P450 Enzyme-Substrate Selectivity
- (2012) Tao Zhang et al. Molecular Informatics
- Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells
- (2012) N Chapman-Rothe et al. ONCOGENE
- miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
- (2012) M T M van Jaarsveld et al. ONCOGENE
- Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
- (2012) C Zeller et al. ONCOGENE
- Involvement of autophagy in ovarian cancer: a working hypothesis
- (2012) Claudia Peracchio et al. Journal of Ovarian Research
- Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer
- (2011) P. A. Konstantinopoulos et al. CANCER RESEARCH
- Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells
- (2011) L. Rosano et al. CLINICAL CANCER RESEARCH
- Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
- (2011) R. K. Amaravadi et al. CLINICAL CANCER RESEARCH
- Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications
- (2011) S. E. Polo et al. GENES & DEVELOPMENT
- Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1
- (2011) Chun Yang et al. GYNECOLOGIC ONCOLOGY
- MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance
- (2011) G. Ye et al. JOURNAL OF CELL SCIENCE
- miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1
- (2011) Fanfei Kong et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Expression of OATP Family Members in Hormone-Related Cancers: Potential Markers of Progression
- (2011) Heather Pressler et al. PLoS One
- Melatonina: modulador de morte celular
- (2011) Cecília da Silva Ferreira et al. Revista da Associacao Medica Brasileira
- The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
- (2010) S. Leskela et al. ENDOCRINE-RELATED CANCER
- Reactive oxygen species in cancer
- (2010) Geou-Yarh Liou et al. FREE RADICAL RESEARCH
- MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
- (2010) Zhimin Li et al. GYNECOLOGIC ONCOLOGY
- MicroRNAs in ovarian cancer biology and therapy resistance
- (2010) Marijn T.M. van Jaarsveld et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
- (2010) Alex Chang LUNG CANCER
- Regulation of Copper Transporter 2 Expression by Copper and Cisplatin in Human Ovarian Carcinoma Cells
- (2010) B. G. Blair et al. MOLECULAR PHARMACOLOGY
- Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
- (2010) S. B. Howell et al. MOLECULAR PHARMACOLOGY
- The Role of Dysregulated Glucose Metabolism in Epithelial Ovarian Cancer
- (2010) L. D. Kellenberger et al. Journal of Oncology
- Reversal of ABC Drug Transporter-Mediated Multidrug Resistance in Cancer Cells: Evaluation of Current Strategies
- (2010) Chung-Pu Wu et al. Current Molecular Pharmacology
- Epithelial–mesenchymal transition in ovarian cancer
- (2009) Daniele Vergara et al. CANCER LETTERS
- MicroRNAs in ovarian carcinomas
- (2009) Neetu Dahiya et al. ENDOCRINE-RELATED CANCER
- The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress
- (2009) Truyen Nguyen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1α
- (2009) Lei Huang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Pharmacogenetics of Membrane Transporters: An Update on Current Approaches
- (2009) Tristan M. Sissung et al. MOLECULAR BIOTECHNOLOGY
- Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance
- (2009) E. A. Perez MOLECULAR CANCER THERAPEUTICS
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
- (2009) Nawneet K. Kurrey et al. STEM CELLS
- Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells
- (2008) Hua Zhu et al. BIOCHEMICAL PHARMACOLOGY
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
- (2008) X.-J. Wang et al. CARCINOGENESIS
- Is cancer a disease of abnormal cellular metabolism? New angles on an old idea
- (2008) Ralph J Deberardinis GENETICS IN MEDICINE
- Role of microRNAs in drug-resistant ovarian cancer cells
- (2008) Antonio Sorrentino et al. GYNECOLOGIC ONCOLOGY
- ABC multidrug transporters: structure, function and role in chemoresistance
- (2007) Frances J Sharom PHARMACOGENOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More